Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-23-002128
Filing Date
2023-04-04
Accepted
2023-04-03 19:20:58
Documents
70
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K sunshine_i10k-123122.htm   iXBRL 10-K 1123499
2 SUBSIDIARIES sunshine_ex2100.htm EX-21 2236
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM sunshine_ex2301.htm EX-23.1 2512
4 CERTIFICATION sunshine_ex3101.htm EX-31.1 10724
5 CERTIFICATION sunshine_ex3102.htm EX-31.2 10727
6 CERTIFICATION sunshine_ex3201.htm EX-32.1 5241
12 GRAPHIC image_002.jpg GRAPHIC 6215
13 GRAPHIC image_004.jpg GRAPHIC 12912
14 GRAPHIC image_005.jpg GRAPHIC 6733
  Complete submission text file 0001683168-23-002128.txt   4736088

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20221231.xsd EX-101.SCH 37901
8 XBRL CALCULATION FILE sbfm-20221231_cal.xml EX-101.CAL 56652
9 XBRL DEFINITION FILE sbfm-20221231_def.xml EX-101.DEF 141831
10 XBRL LABEL FILE sbfm-20221231_lab.xml EX-101.LAB 294661
11 XBRL PRESENTATION FILE sbfm-20221231_pre.xml EX-101.PRE 245100
64 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10k-123122_htm.xml XML 497401
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41282 | Film No.: 23794540
SIC: 2834 Pharmaceutical Preparations